Evidence map›Paper›PMID 28670469›Full record

ArticleFuture science OA2017

An integrated versatile lab-on-a-chip platform for the isolation and nucleic acid-based detection of pathogens.

Natalia Sandetskaya, Doreen Moos, Harald Pötter, Stefan Seifert, Marcin Jenerowicz, Holger Becker, Christian Zilch, Dirk Kuhlmeier

Abstract read
In one paragraph

Article in Future science OA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Natalia SandetskayaFraunhofer Institute for Cell Therapy & Immunology, Leipzig, 04103, Germany.
Doreen MoosFraunhofer Institute for Cell Therapy & Immunology, Leipzig, 04103, Germany.
Harald PötterFraunhofer Institute for Reliability & Microintegration, Berlin, 13355, Germany.
Stefan SeifertFraunhofer Institute for Reliability & Microintegration, Berlin, 13355, Germany.
Marcin JenerowiczFraunhofer Institute for Reliability & Microintegration, Berlin, 13355, Germany.
Holger BeckerMicrofluidic ChipShop GmbH, Jena, 07747, Germany.
Christian ZilchMagna Diagnostics GmbH, Leipzig, 04109, Germany.
Dirk KuhlmeierFraunhofer Institute for Cell Therapy & Immunology, Leipzig, 04103, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimProcessing of the samples in molecular diagnostics is complex and labor-intensive. An integrated and automated platform for sample preparation and nucleic acid-based detection can significantly relieve this burden for the users.

resultsWe present a prototype of a versatile and integrated platform for the detection of pathogens in various liquid media. We describe a proof-of-concept for the integrated isolation of bacteria, cell lysis with optional DNA extraction, DNA amplification and detection in two different reactions, loop-mediated isothermal amplification and PCR, on a single microfluidic platform.

conclusionThe platform enables the transition from large sample volume to microfluidic format. The design and open interface enable its versatile application for various nucleic acid-based assays, from simple to complex setups.

Indexed as

integrated sample preparationlab-on-a-chipLAMPmagnetic particlesPCR

Identifiers

PMID28670469
PMCPMC5481810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.